EU To Reportedly Let Certain Vaccine Contracts Expire

EU To Reportedly Let Certain Vaccine Contracts Expire

Assessment

Interactive Video

Health Sciences, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

The transcript discusses vaccine contracts with Johnson & Johnson and Astra Zeneca, citing an Italian newspaper. It highlights reports of rare blood clots in Europe after Astra Zeneca shots and the EU's complaints about not receiving the expected doses from Astra Zeneca. The EU also faces similar delays with Johnson & Johnson's vaccine shipments.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which two companies are mentioned in the context of vaccine contracts for the next year?

Moderna and Astra Zeneca

Johnson and Johnson and Astra Zeneca

Pfizer and Johnson and Johnson

Pfizer and Moderna

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What issue was reported in Europe after receiving the Astra Zeneca vaccine?

Mild fever

Ultra rare blood clots

Nausea

Severe headaches

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What was the EU's complaint regarding Astra Zeneca's vaccine delivery?

The vaccine was too expensive

The vaccine was not effective

The EU did not receive the number of doses it paid for

The vaccine had a short shelf life

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

How many doses was Astra Zeneca expected to deliver to the EU by the end of March?

80 million doses

150 million doses

50 million doses

120 million doses

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which other company's vaccine faced similar delivery delays to the EU?

Moderna

Pfizer

Johnson and Johnson

Sinovac